Viewing Study NCT00003961

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:24 PM
Ignite Modification Date: 2026-02-02 @ 1:43 AM
Study NCT ID: NCT00003961
Status: COMPLETED
Last Update Posted: 2014-04-17
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Myelodysplastic Syndromes View
None Myelodysplastic/Myeloproliferative Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None refractory anemia with excess blasts View
None refractory anemia with excess blasts in transformation View
None chronic myelomonocytic leukemia View
None de novo myelodysplastic syndromes View
None previously treated myelodysplastic syndromes View
None secondary myelodysplastic syndromes View
None refractory cytopenia with multilineage dysplasia View
None atypical chronic myeloid leukemia View
None myelodysplastic/myeloproliferative disease, unclassifiable View